Police Customers or Pet Lovers? Axon vs. Chewy in 2026

Axon offers faster growth; Chewy has the sturdier repeat model

Chewy looks more durable if you want steady repeat demand. Axon looks more attractive if you are willing to pay for faster growth and deeper software integration.

Chewy's edge is straightforward: it sells pet food, treats, supplies, and medications to households that keep coming back. The repeat engine is the clearest proof. Autoship customer sales grew 10.5% and accounted for 84.4% of total net sales. That kind of customer habit can help a business hold up better when the consumer backdrop softens.

Axon is the faster-moving story. It sells Connected Devices and Software & Services, and management is explicitly trying to build an operating system for public safety. Revenue supports that momentum: Total revenues were $904.4 million, up 35.3% year over year, and the company raised its full-year revenue growth outlook to 32% to 34%. If the ecosystem keeps pulling agencies deeper into Axon's workflow, that could support a premium valuation.

The portfolio choice is fairly clean: prefer Chewy for steadier repeat demand, and choose Axon if you want exposure to a richer multiple tied to software stickiness.

Axon's advantage is workflow depth, not one-time equipment sales

Axon's edge is not that police departments buy a gadget once. It is that the company is trying to cover more of an agency's workflow, from response to evidence management. That workflow already includes Axon Evidence, Axon Records, and Axon Respond, alongside Training products. The strategic point is operational: the more of daily workflow sits inside Axon's stack, the costlier it becomes for an agency to replace just one piece.

Software growth is reinforcing the platform story

Axon is starting to look less like a pure hardware seller and more like a platform seller. In the latest quarter, Software & Services revenue rose 36.2%. Connected Devices revenue also grew strongly, up 34.6% year over year, so this is not a case of hardware stalling while software carries the story. Rather, existing customers appear to be putting more of their budget inside Axon's ecosystem.

That view is consistent with Axon's own update that Annual recurring revenue grows 39% to $1.6 billion. The takeaway is simple:Axon is not relying only on isolated equipment purchases. It is deepening wallet share inside each agency over time.

The premium valuation leaves less room for error

The bear case is mostly about valuation. Axon still trades at a P/E Ratio of 225.27, so the stock already reflects high expectations for future lock-in and margin resilience. There is also a near-term mix question: Software & Services adjusted gross margin decreased to 75.1% as the company mixed in more professional services and newer offerings.

Over the next few quarters, the key signal is whether premium software adoption and ecosystem adoption continue to outrun the expectations already embedded in the stock.

Chewy's case is scale, loyalty, and a tougher consumer test

Chewy's appeal is less dramatic than Axon's, but the business logic is easy to respect.

The latest quarter showed growth with discipline

In the latest quarter, active customers grew to 21.5 million, adding nearly 200,000 net customers. Net sales per active customer also rose to $597 from $583. That matters because Chewy does not need a new category to win. It needs a large customer base to keep showing up and spending a bit more.

Even in a more challenging consumer environment, Chewy posted 7.7% net sales growth and record quarterly profit. That is the core of the bull case: scale is increasing without a clear loss of discipline in profitability.

The trade-off is slower growth, not weaker customer demand

The main pressure point for Chewy is that management lowered its full-year revenue guidance to $13.4 billion to $13.55 billion while leaving its adjusted EBITDA margin target unchanged at 6.6% to 6.8%. That points to a modest demand reset rather than a collapse in business quality.

The practical watch item is whether consumer pressure keeps softening revenue growth or starts to pressure margins as well.

For 2026, the better stock depends on the risk you want

Choose Chewy if you prefer a slower consumer reset and a more familiar repeat-sales model. Choose Axon if you believe a very rich stock can keep earning its premium through continued platform adoption and high double-digit growth.

What matters most over the next few quarters

• Chewy: the market's main concern was a more challenging consumer backdrop. If demand stays soft but margin targets hold, the resilience case remains intact.
• Axon: management raised its 2026 outlook to 32% to 34% revenue growth after reporting Q2 2026 earnings on August 4, 2026, reporting an EPS of $1.88, which topped analysts' consensus estimates of $1.84 by $0.04. Quarterly revenue rose 35.3% year-over-year to $904.39 million. If that momentum continues, the premium multiple has a clear operating case behind it.

The real choice is not quality versus weakness. It is whether you prefer Chewy's slower consumer test or Axon's higher-bar execution story.